
About Cology Biosciences
Cology Biosciences is a Healthcare company based in Hyderabad (India) founded in 2022 by Sri Devi. Preclinical research services are offered for pharma and biotech RD. Its chief executive, as recorded, is Sri Devi. Its Indian entity Cology Biosciences Private Limited reported revenue of βΉ13.8 Lakh. Cology Biosciences offers products and services including Pharmacokinetics Services, Pharmacology Services, Toxicology Services, and Diagnostics Services. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified.
Company details
Cology Biosciences was founded in 2022 in Hyderabad, India, as a platform focused on preclinical research in the pharmaceutical, biotechnology, and nutraceutical sectors. Animal experimentation support is provided to address early-stage RD needs through methods such as acute inhalation toxicity studies, dermal irritation tests, and inhalational toxicity evaluations for drug administration technologies. Operations emphasize cost-effective and innovative approaches to preclinical testing.
- Headquarters Hyderabad, India
- Founders Sri Devi
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website cologybiosciences.com
- Social LinkedIn
- Legal Name Cology Biosciences Private Limited
- Date of Incorporation 19 Jul, 2023
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹13.8 Lakh
FY 2024
- Net Profit₹42,224
FY 2024 · 3% margin
- EBITDA₹63,288
FY 2024 · 5% margin
Associated legal entities of Cology Biosciences
Cology Biosciences operates through Cology Biosciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cology Biosciences Private Limited CIN U72100TS2023PTC175135 | Active | 19 Jul 2023 | Hyderabad, Telangana | ₹0.1 Cr | 2 | View details |
Products & Services of Cology Biosciences
Cology Biosciences offers a comprehensive portfolio of products and services, including Pharmacokinetics Services, Pharmacology Services, Toxicology Services, and Diagnostics Services.
Conducts studies on drug absorption, distribution, and metabolism.
Develops animal models for disease and inflammation studies.
Performs acute and chronic toxicity tests for drug safety.
Offers haematology and biochemistry tests for various species.
Board of directors of Cology Biosciences Private Limited (Cology Biosciences)
Cology Biosciences Private Limited is the primary company behind Cology Biosciences. The board of Cology Biosciences Private Limited currently have 2 directors; the longest-serving is Mohini Sridevi Kothapalli, appointed in 2023.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mohini Sridevi Kothapalli DIN 10244972 | Director | 19 Jul 2023 | 3 yrs 3 mo | Cology Biosciences Private Limited |
| Venkata Sitarama Raju Kothapalli DIN 10244971 | Director | 19 Jul 2023 | 3 yrs 3 mo | Cology Biosciences Private Limited |
People of Cology Biosciences
1 people are tracked at Cology Biosciences (1 in leadership).
| Name | Role | Group |
|---|---|---|
Sri Devi | Founder & CEO | Leadership |
Complete people profiles for Cology Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Cology Biosciences
Figures of Cology Biosciences Private Limited, the primary company behind Cology Biosciences, for FY 2024. Revenue was ₹13.8 Lakh. Net profit was ₹42,224 (3% margin). EBITDA was ₹63,288 (5% margin).
- ₹13.8 LakhRevenue · FY 2024
- ₹42,224Net profit · 3% margin
- ₹63,288EBITDA · 5% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Cology Biosciences Private Limited are on its company page.
Detailed financial statements for Cology Biosciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Cology Biosciences (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cology Biosciences
Cology Biosciences was founded in 2022.
Cology Biosciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Sri Devi is the CEO of Cology Biosciences, as recorded in our data. They have also founded this company.
The primary company behind Cology Biosciences, Cology Biosciences Private Limited, reported revenue of βΉ13.8 Lakh for FY 2024.
Cology Biosciences was founded in 2022 in Hyderabad, India, as a platform focused on preclinical research in the pharmaceutical, biotechnology, and nutraceutical sectors. Animal experimentation support is provided to address early-stage RD needs through methods such as acute inhalation toxicity studies, dermal irritation tests, and inhalational toxicity evaluations for drug administration technologies. Operations emphasize cost-effective and innovative approaches to preclinical testing.
Cology Biosciences offers Pharmacokinetics Services, Pharmacology Services, Toxicology Services, and Diagnostics Services.
Cology Biosciences operates through Cology Biosciences Private Limited.
The legal entities of Cology Biosciences currently have 2 directors, including Mohini Sridevi Kothapalli, Venkata Sitarama Raju Kothapalli.